Nonsteroidal antiinflammatory drug use and gallstone disease prevalence: A case-control study

American Journal of Gastroenterology

Volumn 93, Issue 9, 1998, Pages 1420-1424

  Pazzi, Paolo ^a   Scagliarini, Raffaella ^a   Sighinolfi, Davide ^a   Govoni, Marcello ^a   La Corte, Renato ^a   Gullini, Sergio ^a  

^a S ANNA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG USE; FEMALE; GALLSTONE; GALLSTONE FORMATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT;

AGE FACTORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; CASE-CONTROL STUDIES; CHOLECYSTECTOMY; CHOLELITHIASIS; CHOLESTEROL; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; SEX FACTORS;

EID: 0032172830     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00453.x     Document Type: Article

References (32)

1. 1. Sedaghat A, Grundy SM. Cholesterol crystals and the formation of cholesterol gallstones. N Engl J Med 1980;302:1274-7.
2. 2. Holzbach RT, Marsh M, Olsezwski M, et al. Cholesterol solubility in bile: evidence that supersatured bile is frequent in healthy men. J Clin Invest 1973;52:1467-71.
3. 3. Holan KR, Holzbach RT, Hermann RE, et al. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979;77:611-7.
4. 4. Marks JW, Bonnoris GG, Albers G, et al. The sequence of biliary events preceding the formation of gallstones in humans. Gastroenterology 1992;103:655-70.
5. 5. Everson GT. Gallbladder function in gallstone disease. Gastroenterol Clin North Am 1991;20:85-110.
6. 6. Levy PF, Smith BF, La Mont JT. Human gallbladder mucin accelerates nucleation in artificial bile. Gastroenterology 1984;87:270-5.
7. 7. Lee SP, Carey MC, La Mont JT. Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 1981;211:1429-31.
8. 8. O'Leary DP, La Morte WW, Scott TE, et al. Inhibition of prostaglandin synthesis fails to prevent gallbladder mucin hypersecretion in the cholesterol-fed prairie dog. Gastroenterology 1991;101:812-20.
9. 9. Booker ML, Scott TE, La Morte WW. Effect of dietary cholesterol in phosphatidylcholines and phosphatidylethanolamines in bile and gallbladder mucosa in prairie dog. Gastroenterology 1989;97:1261-7.
10. 10. Rhodes M, Allen A, Dowling RH, et al. Inhibition of human gallbladder mucus synthesis in patients undergoing cholecystectomy. Gut 1992;33:1113-7.
11. 11. Friendlander TM, Davidson JS, Shaffer EA. Defective gallbladder contractility in the ground squirrel and prairie dog during the early stages of cholesterol gallstone formation. Gastroenterology 1983;85: 830-6.
12. 12. O'Donnel LJD, Wilson P, Guest P, et al. Indomethacin and post-prandial gallbladder emptying. Lancet 1992;339:269-71.
13. 13. Cohen BI, Moshbach EH, Ayyad H, et al. Aspirin does not inhibit cholesterol cholelithiasis in two established animal models. Gastroenterology 1991;101:1109-16.
14. 14. La Morte WW, O'Leary DP, Scott TE, et al. Inhibition of prostaglandin synthesis fails to prevent gallbladder mucin secretion or gallstones nucleation in the cholesterol-fed prairie dog. Gastroenterology 1990; 98:A253.
15. 15. Li YF, Russell DH, Myers SI, et al. Effects of aspirin on gallbladder contractility in cholesterol fed prairie dogs. Gastroenterology 1990;98: A254.
16. 16. Brotschi EA, La Morte WW, Williams LF. Effect of dietary cholesterol and indomethacin on cholelithiasis and gallbladder motility. Dig Dis Sci 1984;29:1050-6.
17. 17. Hood C, Gleeson D, Ruppin DC, et al. Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs. Lancet 1988;ii: 1223-5.
18. 18. Broomfield PH, Chopra R, Sheinbaum RC, et al. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss weight. N Engl J Med 1988;319:1567-72.
19. 19. Sterling RK, Shiffman ML, Sugerman HJ, et al. Effect of NSAIDs on gallbladder bile composition. Dig Dis Sci 1995;40:2220-6.
20. 20. Attili AF, Carulli N, Roda E, et al. Epidemiology of Gallstone Disease in Italy: Prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.). Am J Epidemiol 1995;141:158-65.
21. 21. Lee SP, La Mont JT, Carey CM. Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones. J Clin Invest 1981; 67:1712-23.
22. 22. Marom Z, Shelhamer JH, Kaliner M. Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucus glycoproteins from human airways in vitro. J Clin Invest 1981;67:1695-702.
23. 23. Myers SI, Li YF, Weisbrodt NW, et al. Endogenous gallbladder prostaglandin biosynthesis is not related to gallstone formation in the prairie dog fed a high-cholesterol diet. Surg Forum 1989;40:157-8.
24. 24. Rhodes M, Allen A, Lennard TWJ. Mucus glycoprotein biosynthesis in the human gallbladder: inhibition by aspirin. Gut 1992;33:1109-12.
25. 25. Afdhal NH, Gong D, Niu N, et al. Cholesterol cholelithiasis in the prairie dog: role of mucin and non-mucin glycoproteins. Hepatology 1993;17:693-700.
26. 26. Adamek HE, Buttmann A, Weber J, et al. Can aspirin prevent gallstone recurrence after successful extracorporeal shockwave lithotripsy? Scand J Gastroenterol 1994;29:355-9.
27. 27. Sahlin A, Ahlberg J, Einarsson K, et al. The effect of aspirin on gallbladder epithelium and bile composition in patients with gallstone. Eur J Gastroenterol & Hepatol 1992;4:1019-24.
28. 28. Goldman G, Kahn PJ, Alon R, et al. Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibition. Dig Dis Sci 1989; 34:809-11.
29. 29. Kurata JH, Marks J, Abbey D. One gram of aspirin per day does not reduce risk of hospitalization for gallstone disease. Dig Dis Sci 1991; 16:1110-5.
30. 30. Das A, Baijal SS, Saraswat VA. Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double-blind, placebo-controlled trial of two dosage schedules. Dig Dis Sci 1995;40:1782-5.
31. 31. Murray FE, Hawkey CJ. Effect of indomethacin and mysoprostol on fasted gallbladder volume and meal-induced gallbladder contractility in humans. Dig Dis Sci 1992;8:1228-31.
32. 32. Shiffman ML, Shamburek RD, Schwartz CC, et al. Gallbladder mucin, arachidonic acid and bile lipids in patients who develop gallstones during weight reduction. Gastroenterology 1993;105:1200-8.